Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges
Time 1 Minute Read

Recently, Aegerion Pharmaceuticals announced that it will enter into several settlements and plead guilty to two misdemeanors in connection with alleged violations of HIPAA, drug marketing regulations and securities laws. The criminal charges stem from the company’s marketing of a cholesterol drug called Juxtapid. Aegerion allegedly failed to comply with risk evaluation and management strategies and marketed Juxtapid (which is labeled with a warning about liver toxicity) without proper directions for use. 

Aegerion will also pay $40 million to settle claims by the Department of Justice and Securities and Exchange Commission, and enter into a deferred prosecution agreement related to alleged violations of HIPAA. The specific violations of HIPAA have not been made public, but an Aegerion spokesperson stated that it “does not relate to a breach of our privacy or security with respect to patient health information.”

You May Also Be Interested In

Time 2 Minute Read

The U.S. Department of Health and Human Services’ Office for Civil Rights recently announced a settlement with health care software company MMG Fusion to resolve the company’s alleged noncompliance with the HIPAA Privacy, Security and Breach Notification Rules.

Time 4 Minute Read

Recent changes to 42 CFR Part 2 mean many covered entities must update their HIPAA Notices of Privacy Practices by February 16, 2026.

Time 2 Minute Read

On March 5, 2026, the California Privacy Protection Agency announced that the agency had reached a settlement with Ford Motor Company resolving an enforcement action against the company that alleged noncompliance with the California Consumer Privacy Act’s opt-out of sale/sharing rights.

Time 2 Minute Read

On February 19, 2026, the U.S. Department of Health and Human Services’ Office for Civil Rights announced a $103,000 settlement with Top of the World Ranch Treatment Center, an Illinois substance use disorder treatment provider, to resolve alleged noncompliance with the HIPAA Security Rule’s risk analysis requirement.

Search

Subscribe Arrow

Recent Posts

Categories

Tags

Archives

Jump to Page